Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) CFO Kory James Wentworth sold 950 shares of the firm’s stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $13.48, for a total transaction of $12,806.00. Following the completion of the transaction, the chief financial officer now directly owns […]
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) fell 6% on Monday . The company traded as low as $15.40 and last traded at $15.42. 19,255 shares traded hands during mid-day trading, a decline of 74% from the average session volume of 73,412 shares. The stock had previously closed at $16.41. Wall Street Analyst Weigh […]
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) insider Nerissa Kreher sold 10,348 shares of the firm’s stock in a transaction dated Wednesday, August 2nd. The shares were sold at an average price of $15.19, for a total transaction of $157,186.12. Following the completion of the sale, the insider now owns 27,130 shares in the […]
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) insider Natarajan Sethuraman sold 3,026 shares of Entrada Therapeutics stock in a transaction that occurred on Monday, July 10th. The stock was sold at an average price of $18.00, for a total value of $54,468.00. Following the completion of the transaction, the insider now owns 168,299 shares […]
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) CFO Kory James Wentworth sold 3,884 shares of Entrada Therapeutics stock in a transaction on Tuesday, July 11th. The shares were sold at an average price of $18.00, for a total value of $69,912.00. Following the sale, the chief financial officer now directly owns 36,747 shares of […]